Transcutaneous Vibro-Acoustic Therapy in Parkinson Disease
Stopped early · Not applicable
Conditions studied: Parkinson Disease
In brief
Small exploratory pilot study to assess effects of a transcutaneous vibro-acoustic therapy device (Apollo Neuro) in people with Parkinson's disease (PD).
Key facts
- Study ID
- NCT05962476
- Run by
- University of Michigan
- People needed
- 1
- Starts
- 2023-08-09
- Expected to finish
- 2023-08-09
- Last updated by the study team
- 2025-08-01
Who can join
Age: 40 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosed with Parkinson's Disease (Hoehn and Yahr stage 2 or higher)
- Individuals on or off dopaminergic therapy
- Present of anxiety or panic disorder
- Fear of falling
- Understanding of use and care of smart phones and devices
You may not qualify if…
- Presence of significant dementia
- Disorders which may resemble PD, such as dementia with Lewy bodies, vascular dementia, normal pressure hydrocephalus, multiple system atrophy, corticobasal ganglionic degeneration, or toxic causes of parkinsonism.
- Patients with a cardiac pacemaker
- History of brain surgery or placement of a deep brain stimulator
- Psoriasis vulgaris (or other inflammatory skin condition) on or near skin where the vibro-acoustic device and sleep tracking ring will be donned.
- Patients on beta-blockers, benzodiazepines, antipsychotics, and stimulants (except for the treatment of attention deficit disorder/ADHD).
- Pregnancy
- Patients who begin cognitive behavioral therapy or a selective serotonin reuptake inhibitor (SSRI) medication for an anxiety disorder or other psychiatric disorder after the baseline clinical assessment.
Where it is running
- Domino's Farms — Ann Arbor, Michigan, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.